AIF in $40m Indian pharma deal

The Hong Kong-based private equity firm’s investment in Famy Care will assist the company’s expansion into developed markets.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this